Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles (2018)
- Authors:
- Autor USP: WRENGER, CARSTEN - ICB
- Unidade: ICB
- DOI: 10.1007/s00204-018-2165-4
- Subjects: PARASITOLOGIA; ANTAGONISMO DE DROGAS; CÉLULAS KUPFFER
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2018
- Source:
- Título: Archives of Toxicology
- ISSN: 1432-0738
- Volume/Número/Paginação/Ano: v. 92, p. 1435-1451, 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BURK, Oliver et al. Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles. Archives of Toxicology, v. 92, p. 1435-1451, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00204-018-2165-4. Acesso em: 25 fev. 2026. -
APA
Burk, O., Kuzikov, M., Kronenberger, T., Jeske, J., Keminer, O., Thasler, W. E. , et al. (2018). Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles. Archives of Toxicology, 92, 1435-1451. doi:10.1007/s00204-018-2165-4 -
NLM
Burk O, Kuzikov M, Kronenberger T, Jeske J, Keminer O, Thasler W E , Schwab M, Wrenger C, Windshügel B. Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles [Internet]. Archives of Toxicology. 2018 ; 92 1435-1451.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1007/s00204-018-2165-4 -
Vancouver
Burk O, Kuzikov M, Kronenberger T, Jeske J, Keminer O, Thasler W E , Schwab M, Wrenger C, Windshügel B. Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles [Internet]. Archives of Toxicology. 2018 ; 92 1435-1451.[citado 2026 fev. 25 ] Available from: https://doi.org/10.1007/s00204-018-2165-4 - Oxidative stress in human infectious diseases - present and current - knowledge about its druggability
- Purification, crystallization and preliminary X-ray diffraction analysis of pyridoxal kinase from Plasmodium falciparum (PfPdxK)
- Exploring inhibition of Pdx1, a component of the PLP synthase complex of the human malaria parasite Plasmodium falciparum
- Trafficked Proteins—Druggable in Plasmodium falciparum?
- In vitro activity of extracts and isolated polyphenols from West African medicinal plants against Plasmodium falciparum
- Oxidative stress control by apicomplexan parasites
- Identification of a non-competitive inhibitor of Plasmodium falciparum aspartate transcarbamoylase
- Molecular modeling applied to nucleic acid-based molecule development
- Crystallization and preliminary X-ray diffraction of malate dehydrogenase from Plasmodium falciparum
- The antioxidative effect of de novo generated vitamin B6 in Plasmodium falciparum validated by protein interference
Informações sobre o DOI: 10.1007/s00204-018-2165-4 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
